risperidone has been researched along with Stuttering in 8 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Stuttering: A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, double-blind, placebo-controlled study was conducted to assess the efficacy of risperidone in the treatment of developmental stuttering in 16 adults." | 9.09 | Risperidone for the treatment of stuttering. ( Franklin, DL; Gottschalk, LA; Maguire, GA; Riley, GD, 2000) |
| "A randomized, double-blind, placebo-controlled study was conducted to assess the efficacy of risperidone in the treatment of developmental stuttering in 16 adults." | 5.09 | Risperidone for the treatment of stuttering. ( Franklin, DL; Gottschalk, LA; Maguire, GA; Riley, GD, 2000) |
| "Stuttering is a speech disorder characterised by frequent prolongations, repetitions or blocks of spoken sounds and/or syllables." | 2.42 | Alleviating stuttering with pharmacological interventions. ( Franklin, DL; Maguire, GA; Riley, GD; Yu, BP, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Sood, S | 1 |
| Rocha, FF | 1 |
| Tavano, A | 1 |
| Busan, P | 1 |
| Borelli, M | 1 |
| Pelamatti, G | 1 |
| Maguire, GA | 2 |
| Yu, BP | 1 |
| Franklin, DL | 2 |
| Riley, GD | 2 |
| van Wattum, PJ | 1 |
| Ranjan, S | 1 |
| Sawhney, V | 1 |
| Chandra, PS | 1 |
| Gottschalk, LA | 1 |
| Lee, HJ | 1 |
| Lee, HS | 1 |
| Kim, L | 1 |
| Lee, MS | 1 |
| Suh, KY | 1 |
| Kwak, DI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label Study to Evaluate the Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).[NCT02909088] | Phase 2/Phase 3 | 10 participants (Anticipated) | Interventional | 2016-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for risperidone and Stuttering
| Article | Year |
|---|---|
Alleviating stuttering with pharmacological interventions.
Topics: Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Fronta | 2004 |
1 trial available for risperidone and Stuttering
| Article | Year |
|---|---|
Risperidone for the treatment of stuttering.
Topics: Adult; Aged; Analysis of Variance; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; | 2000 |
6 other studies available for risperidone and Stuttering
| Article | Year |
|---|---|
A Case Report of Stuttering Induced by Risperidone and Chlorpromazine.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Haloperidol; Humans; Male; Risperidone; Stutt | 2022 |
[Aripiprazole-induced stuttering treated with risperidone].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Piperazines; Quinolones; Risperidone; Sch | 2009 |
Risperidone reduces tic-like motor behaviors and linguistic dysfluencies in severe persistent developmental stuttering.
Topics: Humans; Language Development Disorders; Linguistics; Male; Risperidone; Severity of Illness Index; S | 2011 |
Stuttering improved with risperidone.
Topics: Antipsychotic Agents; Child, Preschool; Humans; Male; Risperidone; Stuttering | 2006 |
Persistent developmental stuttering: treatment with risperidone.
Topics: Adult; Antipsychotic Agents; Humans; Male; Risperidone; Severity of Illness Index; Stuttering; Treat | 2006 |
A case of risperidone-induced stuttering.
Topics: Adult; Antipsychotic Agents; Humans; Male; Risperidone; Stuttering | 2001 |